Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Proceedings of the National Academy of Sciences of the United States of America|October 20, 2010
Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodesJoshua T Schiffer, Laith Abu-Raddad, Karen E Mark, et al.
Antimicrobial Agents and Chemotherapy|April 9, 2014
Three phase III randomized controlled trials of topical resiquimod 0.01-percent gel to reduce anogenital herpes recurrencesKaren E Mark, Spotswood Spruance, George R Kinghorn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 24, 2011
Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step study)Ruanne V Barnabas, Judith N Wasserheit, Yunda Huang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2005
Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003Heidi M Bauer, Karen E Mark, Michael Samuel, et al.
MMWR. Morbidity and Mortality Weekly Report|February 12, 2016
Occupational HIV Transmission Among Male Adult Film Performers - Multiple States, 2014Jason A Wilken, Christopher Ried, Pristeen Rickett, et al.
The Journal of Infectious Diseases|April 3, 2007
Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trialKaren E Mark, Lawrence Corey, Tze-Chiang Meng, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 17, 2005
Risk factors for infection during a dengue-1 outbreak in Maui, Hawaii, 2001John Mosely Hayes, José G Rigau-Pérez, Paul Reiter, et al.
Pageof 2